Hua Medicine (HUMDF) Financial Statements
Hua Medicine Financial Overview
Hua Medicine's market cap is currently $269.23M. The company's EPS TTM is $-0.10; its P/E ratio is -18.06; Hua Medicine has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 480.18M | $ 255.89M | $ 76.61M | $ 17.60M | $ 0.00 |
| Gross Profit | $ 273.10M | $ 124.72M | $ 37.37M | $ 7.69M | $ -38.48M |
| Operating Income | $ -141.13M | $ -352.64M | $ -289.09M | $ -267.12M | $ -320.52M |
| EBITDA | $ -108.66M | $ -325.72M | $ -167.09M | $ -168.06M | $ -290.08M |
| Net Income | $ 1.08B | $ -250.14M | $ -211.23M | $ -203.77M | $ -330.95M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.09B | $ 1.14B | $ 1.46B | $ 490.63M | $ 675.24M |
| Total Assets | $ 1.47B | $ 1.53B | $ 1.73B | $ 1.12B | $ 903.55M |
| Total Debt | $ 301.80M | $ 300.18M | $ 167.75M | $ 97.58M | $ 71.53M |
| Net Debt | $ -790.95M | $ -839.57M | $ -1.29B | $ -393.05M | $ -603.71M |
| Total Liabilities | $ 463.48M | $ 1.66B | $ 1.62B | $ 841.92M | $ 453.22M |
| Stockholders' Equity | $ 1.01B | $ -135.47M | $ 101.15M | $ 279.58M | $ 450.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -59.70M | $ -421.83M | $ 879.52M | $ -257.58M | $ -339.87M |
| Operating Cash Flow | $ -52.15M | $ -417.97M | $ 889.37M | $ -230.11M | $ -272.98M |
| Investing Cash Flow | $ -654.00K | $ 10.04M | $ 8.08M | $ -4.75M | $ -68.22M |
| Financing Cash Flow | $ 9.10M | $ 83.72M | $ 69.07M | $ 21.48M | $ -6.13M |
Currency in CNY
